Intuitive Surgical's Q1 2025: Revenue Surge Driven by Robotic Surgery
Sunnyvale, Wednesday, 23 April 2025.
Intuitive Surgical reported a notable 19% increase in Q1 2025 revenue, reaching €2.25 billion, fueled by a 17% rise in da Vinci robotic procedures, reflecting growing trust in robotic-assisted surgeries.
Strong Q1 Financial Performance
Intuitive Surgical, Inc. (Nasdaq: ISRG) announced a robust financial performance for the first quarter of 2025, with revenues rising 19% year-over-year to €2.25 billion, fueled by increased adoption of its robotic-assisted surgical systems, notably the da Vinci lineup. The gain in revenues underscores the growing trust in robotic surgery as a preferred method for minimally invasive procedures [1][2].
Surge in da Vinci System Deployments
The quarter saw the placement of 367 da Vinci surgical systems, which included 147 of the latest da Vinci 5 models. This marks a significant increase from the previous year’s Q1 figures of 313 total systems, inclusive of just 8 da Vinci 5 models. Such deployment growth mirrors the healthcare sector’s confidence in leveraging advanced robotic technologies for enhanced surgical accuracy and efficiency [1][3].
Expansion of Installed Base and Procedure Growth
By the end of March 2025, Intuitive’s installed base of da Vinci systems had reached 10,189, reflecting a 15% rise from 8,887 systems as of March 2024. Additionally, the volume of worldwide da Vinci procedures increased by 17%, showcasing a strong trajectory in procedural adoption across facilities globally [1][2][3].
Executive Commentary and Outlook
Intuitive Surgical’s CEO, Gary Guthart, expressed satisfaction with the quarter’s performance, attributing the positive results to the robust adoption of cutting-edge systems like the da Vinci 5. Looking ahead, the company projects a surgical procedure growth rate of 15%-17% for the entirety of 2025, a continued reflection of the marketplace’s robust acceptance of robotic surgery methodologies [1][2].